Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03758417 |
| Consolidated Lead Sponsor | Nanjing Legend Biotech |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 123 participants (ACTUAL) |
| Registered Start Date | 2019-01-23 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Nanjing Drum Tower Hospital | Nanjing, China | Open Hospital Dossier -> |
| Jiangsu Province Hospital | Nanjing, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.